On September 25, 2025, former U.S. President Donald Trump sent shockwaves through the global pharmaceutical and trade landscape with a daring announcement: starting October 1, the United States will slap a 100% tariff on imports of branded or patented pharmaceutical drugs—unless the drugmaker is actively building a manufacturing facility right here in the U.S. This bold declaration, shared on Trump’s…